{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:32:31Z","timestamp":1785717151818,"version":"3.56.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"43","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.vaccine.2022.09.056","type":"journal-article","created":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T07:33:37Z","timestamp":1664177617000},"page":"6206-6210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Pneumococcal vaccination among adult risk patient with axial spondyloarthritis in Switzerland: Data from the survey of the ankylosing spondylitis association of Switzerland (SVMB)"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0124-0941","authenticated-orcid":false,"given":"Sandro T.","family":"Stoffel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Colaninno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"Br\u00e4m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Schwenkglenks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2022.09.056_b0005","doi-asserted-by":"crossref","unstructured":"Sieper J, Poddubnyy D. Axial spondyloarthritis. Lancet 2017;390(10089):73\u201384.","DOI":"10.1016\/S0140-6736(16)31591-4"},{"key":"10.1016\/j.vaccine.2022.09.056_b0010","doi-asserted-by":"crossref","unstructured":"Strand V, Singh JA. Patient burden of axial spondyloarthritis. J Clin Rheumatol 2017;23(7):383.","DOI":"10.1097\/RHU.0000000000000589"},{"issue":"11","key":"10.1016\/j.vaccine.2022.09.056_b0015","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1136\/annrheumdis-2018-213590","article-title":"Impact of biological therapy on work outcomes in patients with axial spondyloarthritis: results from the British Society for Rheumatology Biologics Register (BSRBR-AS) and meta-analysis","volume":"77","author":"Shim","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2022.09.056_b0020","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/rheumatology\/kes305","article-title":"The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment","volume":"52","author":"Listing","year":"2013","journal-title":"Rheumatology"},{"key":"10.1016\/j.vaccine.2022.09.056_b0025","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1440-1843.2008.01422.x","article-title":"New insights into pneumococcal disease","volume":"14","author":"Feldman","year":"2009","journal-title":"Respirology (Carlton, Vic)"},{"issue":"2","key":"10.1016\/j.vaccine.2022.09.056_b0030","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/QCO.0000000000000246","article-title":"Pneumococcal vaccination","volume":"29","author":"Cill\u00f3niz","year":"2016","journal-title":"Curr Opin Infect Diseases"},{"key":"10.1016\/j.vaccine.2022.09.056_b0035","unstructured":"Bundesamt f\u00fcr Gesundheit B. Pneumokokkenimpfung: Empfehlungen zur Verhinderung von invasiven Pneumokokkenerkrankungen bei Risikogruppen. BAG Bull 2014;8:129\u201341."},{"key":"10.1016\/j.vaccine.2022.09.056_b0040","unstructured":"Bundesamt f\u00fcr Gesundheit. Schweizerischer Impfplan; 2021. <https:\/\/www.bag.admin.ch\/dam\/bag\/de\/dokumente\/mt\/i-und-b\/richtlinien-empfehlungen\/allgemeine-empfehlungen\/schweizerischer-impfplan.pdf.download.pdf\/schweizerischer-impfplan-de.pdf> [accessed 16 March 2022]."},{"issue":"4","key":"10.1016\/j.vaccine.2022.09.056_b0045","doi-asserted-by":"crossref","first-page":"e0153848","DOI":"10.1371\/journal.pone.0153848","article-title":"Influenza and pneumococcal vaccination uptake in patients with rheumatoid arthritis treated with immunosuppressive therapy in the UK: a retrospective cohort study using data from the clinical practice research datalink","volume":"11","author":"Costello","year":"2016","journal-title":"PLoS ONE"},{"issue":"12","key":"10.1016\/j.vaccine.2022.09.056_b0050","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.vaccine.2015.01.065","article-title":"Low rate of influenza and pneumococcal vaccine coverage in rheumatoid arthritis: data from the international COMORA cohort","volume":"33","author":"Hmamouchi","year":"2015","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2022.09.056_b0055","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1080\/03009742.2016.1242774","article-title":"Factors associated with influenza and pneumococcal vaccine uptake among rheumatoid arthritis patients in Denmark invited to participate in a pneumococcal vaccine trial (Immunovax_RA)","volume":"46","author":"Nguyen","year":"2017","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.vaccine.2022.09.056_b0060","article-title":"Pneumococcal vaccination coverage and uptake among adults in Switzerland: a nationwide cross-sectional study of vaccination records","volume":"9","author":"Zens","year":"2021","journal-title":"Front Public Health"},{"issue":"4","key":"10.1016\/j.vaccine.2022.09.056_b0065","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s12325-013-0025-4","article-title":"Pneumococcal infection\u2014low awareness as a potential barrier to vaccination: results of a European survey","volume":"30","author":"Lode","year":"2013","journal-title":"Adv Therap"},{"issue":"1","key":"10.1016\/j.vaccine.2022.09.056_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12889-016-2784-8","article-title":"Determinants of tetanus, pneumococcal and influenza vaccination in the elderly: a representative cross-sectional study on knowledge, attitude and practice (KAP)","volume":"16","author":"Klett-Tammen","year":"2015","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2022.09.056_b0075","unstructured":"Schweizerische Vereinigung Morbus Bechterew SVMB. Der Verein. <https:\/\/www.bechterew.ch\/der-verein\/> [accessed 30 August 2022]."},{"key":"10.1016\/j.vaccine.2022.09.056_b0080","unstructured":"Schweizerische Vereinigung Morbus Bechterew SVMB. Jahresbericht; 2021. <https:\/\/www.bechterew.ch\/app\/uploads\/SVMB_Jahresbericht_2021_DE.pdf> [accessed 30 August 2022]."},{"key":"10.1016\/j.vaccine.2022.09.056_b0085","unstructured":"Schweizerische Vereinigung Morbus Bechterew SVMB. Morbus Bechterew. Wie geht es den Betroffenen? Resultate der grossen Umfrage. <https:\/\/www.bechterew.ch\/downloads\/> [accessed 16 March 2022]."},{"issue":"1","key":"10.1016\/j.vaccine.2022.09.056_b0090","first-page":"49","article-title":"Clinical evaluation of ankylosing spondylitis in Switzerland","volume":"5","author":"Brunner","year":"2002","journal-title":"Pain Phys"},{"issue":"2","key":"10.1016\/j.vaccine.2022.09.056_b0095","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3390\/vaccines10020311","article-title":"Low adherence to pneumococcal vaccination in lung cancer patients in a tertiary care university hospital in Southern Germany","volume":"10","author":"Mohr","year":"2022","journal-title":"Vaccines"},{"issue":"1","key":"10.1016\/j.vaccine.2022.09.056_b0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.11648\/j.ajtas.20160501.11","article-title":"Comparison of convenience sampling and purposive sampling","volume":"5","author":"Etikan","year":"2016","journal-title":"Am J Theor Appl Stat"},{"key":"10.1016\/j.vaccine.2022.09.056_b0105","unstructured":"Schweizerische Vereinigung Morbus Bechterew SVMB. Krankheitsbild. <https:\/\/www.bechterew.ch\/krankheitsbild-bechterew\/> [accessed 16 March 2022]."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22011641?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22011641?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:17:45Z","timestamp":1759403865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22011641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":21,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0264410X22011641"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.09.056","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pneumococcal vaccination among adult risk patient with axial spondyloarthritis in Switzerland: Data from the survey of the ankylosing spondylitis association of Switzerland (SVMB)","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.09.056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}